Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ELANE | P08246 | 2/20 | 0.31 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.31 |
| ▸ | SCN9A | Q15858 | 1/20 | 0.31 |
| ▸ | ALOX5AP | P20292 | 1/20 | 0.30 |
| ▸ | FEN1 | P39748 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20155938 | 0.91 | — | — | |
| SCHEMBL20150399 | 0.89 | RXRA (0.34) | ELANE | |
| SCHEMBL20156216 | 0.89 | RXRA (0.34) | ELANESCN9A | |
| SCHEMBL20848784 | 0.88 | ALOX5AP (0.34) | ELANECYP2C9SCN9AALOX5APFEN1 | |
| SCHEMBL20848711 | 0.87 | CYP2C9 (0.33) | ELANECYP2C9SCN9AALOX5APFEN1 | |
| SCHEMBL20155963 | 0.87 | PTGER4 (0.34) | ELANE | |
| SCHEMBL20848794 | 0.86 | KIF11 (0.36) | CYP2C9SCN9AALOX5APFEN1 | |
| SCHEMBL20849276 | 0.86 | KIF11 (0.36) | CYP2C9SCN9AALOX5APFEN1 | |
| SCHEMBL20848787 | 0.86 | PTGER4 (0.37) | ELANECYP2C9SCN9AALOX5APFEN1 | |
| SCHEMBL20848976 | 0.85 | CYP2C9 (0.33) | ELANECYP2C9SCN9AALOX5APFEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10421746-B2 | Organic molecules, especially for use in organic optoelectronic devices | CYNORA GMBH (DE) | 2019-09-24 | — | — | US | disclosed |
| US-20180134686-A1 | ORGANIC MOLECULES, ESPECIALLY FOR USE IN ORGANIC OPTOELECTRONIC DEVICES | CYNORA GMBH (DE) | 2018-05-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180134686-A1 | ORGANIC MOLECULES, ESPECIALLY FOR USE IN ORGANIC OPTOELECTRONIC DEVICES | OR10J3, EPCAM, F12 | ELANE 3607/4885CYP2C9 632/4885SCN9A 812/4885 |
| US-10421746-B2 | Organic molecules, especially for use in organic optoelectronic devices | OR10J3, EPCAM, F12 | ELANE 3607/4885CYP2C9 632/4885SCN9A 812/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.